Automated
Scalable
Accessible
Automated
Scalable
Accessible
Limula offers a unique technology supporting routine manufacturing of highly-personalised cell therapies. We address one of the biggest challenges in this industry - How to enable the transition from open and manual methods towards closed and automated processes?
About Limula
Swiss Made engineering meets cell therapy
Our company is based in Lausanne, Switzerland. We thrive in this world-class ecosystem, tapping into the country’s long tradition of Pharma and Biotech. We have privileged access to exceptional engineering and life science talent and infrastructure, delivering the highest product quality.
Our team
We think out of the box.
We combine decades of experience in different industries to develop a highly innovative and multidisciplinary approach to Cell & Gene Therapy manufacturing.
Leadership
LUC HENRY
Founder and CEO
Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
Yann Pierson
Founder and CTO
Yann graduated from EPFL with a PhD in Chemical Biology and is a certified mechanical designer. He invented, patented and built the first prototype of the technology behind our revolutionary CGT manufacturing platform in his garage during the COVID pandemic lock-down. At Limula, his role is to build an innovative product that meets the performance, quality and regulatory needs of our customers.
Thomas Eaton
Founder and COO
Tom graduated from the University of Basel with a PhD in Material Sciences. Tom has extensive experience in project management, budget tracking, outsourcing and supplier oversight. He has worked for, and consulted to, multinationals, including Deloitte, UBS and SwissRe as a project facilitator. At Limula, his role is to establish company processes to support our objectives and reach our potential.
Team
Olivier Waridel
Head of Product
Olivier is a serial entrepreneur and was the CEO of Biosafe Group SA until 2016 (now part of Cytiva). Under his leadership, the Sepax device became an industry standard for cell processing in biobanks, transplantation centres, hospitals and biopharma. Before joining Limula, he was a consultant for start-up/mid-size life science tools and medical device companies.
Caroline Boudousquié
Head of Applications
Caroline graduated from the University of Lausanne with a PhD in Immunology in 2006 and pursued an academic career in onco-immunology before moving to the biotechnology industry. In 2016, Caroline joined the Center for Experimental Therapeutics of the CHUV where she built and led the Process Development team with the mission to develop and transfer GMP compliant cell therapies manufacturing processes from R&D to GMP production.
Shady Gawad
Head of Digital
Shady earned his PhD in biosensors and microelectronics from EPFL. He is a pioneer in the development of impedance-based sensing technologies for applications in cell biology and immunology. He previously was a Sensor Architect at Léman Micro Devices and a Sensor Designer at Measurement Specialties, Inc (now TE Connectivity).
Maria Elena GRISOSTOLO
Head of Quality
Maria Elena has a decade of experience in medtech companies including Johnson&Johnson, Medtronic and Lunaphore. As VP of Operations at Lunaphore, she played a critical role in the implementation and execution of quality and regulatory affairs, from the company inception to a successful exit.
William Bovy
Product engineer
William earned a BSc in Mechatronics and a MSc in Biomedical Engineering. He spent several years at Debiotech SA, where he developed a strong R&D expertise in medical devices, including a home peritoneal dialysis machine with complex disposable sets. He also has experience in project management and verification activities for FDA approval.
Philippe Mazouer
Senior Software Engineer
Philippe started his career at Philips Healthcare in the Netherlands, developing applications for X-Ray and Ultrasound systems. He was then active in the field of cell and gene therapies with Cytiva.
Carolina Jiménez Navarro
Biotechnologist
Carolina graduated with a MSc in Biology and Biomedicine at the Universidad de Cantabria, Spain. She has gained experience in cell biology and immunology at the University of Fribourg.
Omran El Rifaï
Mechatronics Engineer
Omran brings expertise in designing medical devices and laboratory automation systems. He began his carrier at Lambda Health System, a Swiss start-up active in robotic-based rehabilitation of the lower limbs.
Léo Corsini
Mechatronics Engineer
Léo graduated from HEIG-VD with a BSc degree at the intersection between hardware and software.
Luca Bellosta
Product Specialist
Luca graduated with a MSc in Bioengineering at Politecnico di Milano, Italy. He gained research experience in immuno-engineering at EPFL, Switzerland.
Advisors
Prof. Denis Migliorini
Denis is a practicing physician and Head of Neuro-oncology at the Department of Oncology of the University Hospital of Geneva (HUG), Switzerland. He also leads the Brain Tumour and Immune Cell Engineering Group at the AGORA Cancer Research Center in Lausanne. His research is focused on addressing the most important limitations of CAR T-cell therapy, including specificity, potency and manufacturing hurdles.
Dirk Groenewegen
Dirk is the founder, former CEO and Board Director of Glycostem Therapeutics, a Dutch company pioneering the development of NK and CAR-NK cell therapies for oncology applications. He is a Cell & Gene Therapy consultant and a business development expert supporting Life Science start-ups and early-stage companies.
Friedemann Übele
Friede is the Head Manufacturing Science & Technology at Tigen Pharma. He has gathered significant aseptic process development expertise during his time at Novartis, leading projects for automating and simplifying CGT manufacturing.
Board of directors
LUC HENRY
Founder and CEO
Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
Yann Pierson
Founder and CTO
Yann graduated from EPFL with a PhD in Chemical Biology and is a certified mechanical designer. He invented, patented and built the first prototype of the technology behind our revolutionary CGT manufacturing platform in his garage during the COVID pandemic lock-down. At Limula, his role is to build an innovative product that meets the performance, quality and regulatory needs of our customers.
Thomas Eaton
Founder and COO
Tom graduated from the University of Basel with a PhD in Material Sciences. Tom has extensive experience in project management, budget tracking, outsourcing and supplier oversight. He has worked for, and consulted to, multinationals, including Deloitte, UBS and SwissRe as a project facilitator. At Limula, his role is to establish company processes to support our objectives and reach our potential.
